These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 32004747)

  • 1. Current and Future Treatments of Rhinitis and Sinusitis.
    Patel GB; Kern RC; Bernstein JA; Hae-Sim P; Peters AT
    J Allergy Clin Immunol Pract; 2020 May; 8(5):1522-1531. PubMed ID: 32004747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps.
    Sindwani R; Han JK; Soteres DF; Messina JC; Carothers JL; Mahmoud RA; Djupesland PG
    Am J Rhinol Allergy; 2019 Jan; 33(1):69-82. PubMed ID: 30477309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the evidence for fluticasone exhalation delivery system in chronic rhinosinusitis?
    Kovacs AJ; Goshtasbi K; Kuan EC
    Curr Opin Otolaryngol Head Neck Surg; 2020 Feb; 28(1):14-17. PubMed ID: 31789927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of fluticasone exhalation delivery system in the management of chronic rhinosinusitis: what is the evidence?
    Kuan EC; Kovacs AJ; Workman AD; Bosso JV; Adappa ND
    Int Forum Allergy Rhinol; 2019 May; 9(S1):S16-S21. PubMed ID: 31087635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of EDS-FLU for Chronic Rhinosinusitis: Two Randomized Controlled Trials (ReOpen1 and ReOpen2).
    Palmer JN; Adappa ND; Chandra RK; Davis GE; Mahdavinia M; Messina J; Ow RA; Patel ZM; Peters AT; Sacks H; Schlosser RJ; Sindwani R; Soler ZM; White AA; Wise SK; Mahmoud RA
    J Allergy Clin Immunol Pract; 2024 Apr; 12(4):1049-1061. PubMed ID: 38244014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis.
    Leopold DA; Elkayam D; Messina JC; Kosik-Gonzalez C; Djupesland PG; Mahmoud RA
    J Allergy Clin Immunol; 2019 Jan; 143(1):126-134.e5. PubMed ID: 29928924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of the exhalation delivery system with fluticasone in patients with chronic rhinosinusitis with nasal polyps whose symptoms recur after sinus surgery.
    Ow RA; Soler ZM; Sindwani R; Leopold DA; Lee JT; Mahmoud RA; Han JK
    Int Forum Allergy Rhinol; 2023 Jan; 13(1):31-41. PubMed ID: 35674488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in Smell Using Monoclonal Antibodies Among Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review.
    Barroso B; Valverde-Monge M; Betancor D; Gómez-López A; Villalobos-Vilda C; González-Cano B; Sastre J
    J Investig Allergol Clin Immunol; 2023 Dec; 33(6):419-430. PubMed ID: 37669083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps.
    Patel GB; Peters AT
    Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologics in Chronic Rhinosinusitis: Current and Emerging.
    Boyd JT; Khanwalkar AR
    Immunol Allergy Clin North Am; 2024 Nov; 44(4):657-671. PubMed ID: 39389716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic Therapies for Allergic Rhinitis and Nasal Polyposis.
    Geng B; Dilley M; Anterasian C
    Curr Allergy Asthma Rep; 2021 Jun; 21(6):36. PubMed ID: 34110505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic rhinosinusitis with nasal polyps : is there a place for monoclonal antibodies in 2020 ?].
    Clottu A; Reinhard A; Comte D
    Rev Med Suisse; 2021 Jan; 17(720-1):13-17. PubMed ID: 33443824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Biologics in the Treatment of Nasal Polyps.
    Franzese CB
    Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologics for chronic rhinosinusitis with nasal polyps.
    Bachert C; Zhang N; Cavaliere C; Weiping W; Gevaert E; Krysko O
    J Allergy Clin Immunol; 2020 Mar; 145(3):725-739. PubMed ID: 32145872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhalation Delivery Systems for Application of Intranasal Corticosteroids.
    Kovacs AJ; Adappa ND; Kuan EC
    Ear Nose Throat J; 2021 Jun; 100(5):309-313. PubMed ID: 33305974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EDS-FLU: An important step in appropriate medical therapy for chronic rhinosinusitis with nasal polyps.
    Leopold DA; Elkayam D; Han JK; Soteres DF; Messina JC; Carothers JL; Sacks HJ; Mahmoud RA; Djupesland PG; Sindwani R
    Int Forum Allergy Rhinol; 2022 Jun; 12(6):893-895. PubMed ID: 35348302
    [No Abstract]   [Full Text] [Related]  

  • 17. Dupilumab in chronic rhinosinusitis with nasal polyposis: current status, challenges, and future perspectives.
    Li T; Yin J; Yang Y; Wang G; Zhang Y; Song X
    Expert Rev Clin Immunol; 2023; 19(8):939-948. PubMed ID: 37378551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic rhinosinusitis with nasal polyps (CRSwNP) treated with omalizumab, dupilumab, or mepolizumab: A systematic review of the current knowledge towards an attempt to compare agents' efficacy.
    Papacharalampous GX; Constantinidis J; Fotiadis G; Zhang N; Bachert C; Katotomichelakis M
    Int Forum Allergy Rhinol; 2024 Jan; 14(1):96-109. PubMed ID: 37394893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment options for chronic rhinosinusitis with nasal polyps.
    Wallace DV
    Allergy Asthma Proc; 2021 Nov; 42(6):450-460. PubMed ID: 34871152
    [No Abstract]   [Full Text] [Related]  

  • 20. Real-Life Experience of Monoclonal Antibody Treatments in Chronic Rhinosinusitis with Nasal Polyposis.
    Meier EC; Schmid-Grendelmeier P; Steiner UC; Soyka MB
    Int Arch Allergy Immunol; 2021; 182(8):736-743. PubMed ID: 33756474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.